Cholesterol Optimization (Without Statins)

Cholesterol controversy: LDL-C (standard cholesterol number) is weak predictor of CV risk. Better markers: LDL particle number (LDL-P), ApoB (each LDL particle has one ApoB), small-dense LDL pattern. Can have "normal" LDL-C but high particle number (dangerous) or vice versa. Advanced testing crucial (NMR LipoProfile or Cardio IQ). Inflammation and oxidized LDL drive atherosclerosis, not just LDL level. Mediterranean diet reduces CV events despite minimal LDL lowering (PREDIMED trial) - quality of diet matters more than LDL alone. Niacin (flush form) is most effective natural lipid improver - raises HDL 15-35% (statins barely affect HDL), lowers TG significantly, modestly lowers LDL, improves LDL particle size. But recent trials (AIM-HIGH, HPS2-THRIVE) showed no additional CV benefit when added to statin (controversial - niacin monotherapy not tested). Red yeast rice is natural statin (monacolin K = lovastatin) - works but has statin side effects. Berberine is exciting - multiple mechanisms including upregulating LDL receptors (statin-like), improves insulin sensitivity. Soluble fiber and plant sterols modest but proven effects. Omega-3 lowers TG dramatically, shifts LDL to large particles. Saturated fat controversy: Not as bad as previously thought if from whole foods, but replacing with MUFA (olive oil) or omega-3 improves lipids. Triglycerides and TG:HDL ratio may be better predictors than LDL. Lp(a) is independent genetic risk factor - niacin lowers it (only intervention that does substantially). Many can optimize lipids naturally but some need statins (familial hypercholesterolemia, very high LDL-P, established CAD). Risk assessment should include inflammation, insulin resistance, advanced lipids, family history - not just LDL-C.CV-004